***

Special guest Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute, Lewis and Patricia Dickey Chair in Cardiovascular Medicine, and Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University joins us to talk about non-statins for LDL lowering.

Listen in as they debate which non-statin to use for LDL lowering...due to recent headlines about bempedoic acid.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education at East Tennessee State University
• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Douglas S. Paauw, MD, MACP, Professor of Medicine at the University of Washington School of Medicine
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

For the purposes of disclosure, Dr. Steven Nissen reports relevant financial relationships [cardiology] with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, MyoKardia, New Amsterdam Pharma, Novartis, Pfizer, Silence Therapeutics (grants/research support). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at [email protected]. 

Special guest Nicole Gastala, MD, Assistant Professor from the University of Illinois Chicago Department of Family Medicine and Director of Behavioral Health and Addiction at the Mile Square Health Center joins us to talk about opioid use disorder.

Listen in as they discuss big changes with buprenorphine prescribing for opioid use disorder.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

None of the speakers have anything to disclose.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com.

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at [email protected]. 

Special guest Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute, Lewis and Patricia Dickey Chair in Cardiovascular Medicine, and Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University joins us to talk about medications for type 2 diabetes.

Listen in as they debate whether metformin should still be first-line for all patients with type 2 diabetes...and discuss the role of GLP-1 agonists and SGLT2 inhibitors in these patients.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education at East Tennessee State University
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

For the purposes of disclosure, Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at [email protected]. 

Special guest Laila Khalid, MD, MPH from the Albert Einstein College of Medicine Montefiore Medical Center joins us to talk about new guidelines to reinforce safe opioid use.

Listen in as they discuss what’s changed with the updated CDC opioid guidelines...and what to expect in your practice.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health

None of the speakers have anything to disclose.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com.

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at [email protected]. 

Headache medicine specialist Rebecca C. Burch, MD, joins us to talk about triptan use in patients with cardiovascular risk factors.

Listen in as they clear up confusion about which patients should avoid triptans due to cardiovascular concerns.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University
• Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

For the purposes of disclosure, Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com.

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at [email protected]. 

Special guest Carolyn J. Crandall, MD, MS, MACP, Professor of Medicine at the University of California, Los Angeles School of Medicine joins us to talk about hormone therapy for menopausal symptoms.

Listen in as they clarify when and how to use hormone therapy to manage menopausal symptoms.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education at East Tennessee State University
• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
•  Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University

For the purposes of disclosure, Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at [email protected]. 

TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Dr. Richard H. Dang, PharmD, APh, BCACP, FCPhA, from the University of Southern California and Dr. Elisha Hall, PhD, RD, from the COVID-19 Vaccine Policy Unit at the Centers for Disease Control and Prevention about COVID-19 vaccine boosters.

Listen in as they answer your top questions about updated COVID-19 vaccine boosters.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Douglas S. Paauw, MD, MACP, Professor of Medicine at the University of Washington School of Medicine
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

None of the speakers have anything to disclose. 

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at [email protected]. 

TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Douglas S. Paauw, MD, MACP, Professor of Medicine from the University of Washington School of Medicine about serotonin syndrome.

Listen in as they discuss how to tease out which serotonin syndrome interaction alerts are clinically significant.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education at East Tennessee State University
• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

None of the speakers have anything to disclose. 

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at [email protected]. 

TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Joseph Saseen, PharmD, FCCP, FNLA, Associate Dean for Clinical Affairs, Professor, Department of Clinical Pharmacy and Professor, Department of Family Medicine from the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus about managing statin intolerance. 

Listen in as they discuss how to evaluate statin-associated muscle pain...and review strategies to help patients take a statin successfully. 

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University
• Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

For the purposes of disclosure, Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support).

The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at [email protected]. 

TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Kenneth Cusi, MD, FACP, FACE,  Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism from The University of Florida about managing nonalcoholic fatty liver disease.

Listen in as they discuss considerations with managing nonalcoholic fatty liver disease (NAFLD)...including risk factors, screening, and treatment options.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Douglas S. Paauw, MD, MACP, Professor of Medicine at the University of Washington School of Medicine
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

For the purposes of disclosure, Dr. Cusi reports relevant financial relationships with Echosens, Inventiva, Nordic Pharma, Novo Nordisk, Poxel, Zydus (grants/research support); Ionis, Janssen, Genentech, Gilead, Madrigal, Merck, Novo Nordisk, Pfizer, Poxel, Terns Pharmaceuticals (consultant). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at [email protected].